PAUL JAMES: Open Payments
NPI 1720629512 · LAKE CITY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 18 payments from 9 companies in 2025. Trend: 2023 $165 · 2024 $389 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Lilly USA, LLC | 3 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: GEMTESA, ACCRUFER, MOUNJARO, AIRSUPRA, JARDIANCE, VOQUEZNA, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
